Strict IGF-1 Control in Acromegaly (I-Con Study)

Trial Profile

Strict IGF-1 Control in Acromegaly (I-Con Study)

Phase of Trial: Phase III

Latest Information Update: 11 Oct 2017

At a glance

  • Drugs Pegvisomant (Primary)
  • Indications Acromegaly
  • Focus Therapeutic Use
  • Acronyms I-Con Study
  • Most Recent Events

    • 01 Sep 2017 Status changed from not yet recruiting to recruiting.
    • 10 Jun 2017 Biomarkers information updated
    • 07 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top